Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

For decades, red light therapy has been an adjunct treatment for numerous ailments. But it may not work for all the medical conditions that supporters say it does.

As fossil energy sources gradually deplete, the global demand for energy transformation is becoming increasingly urgent. Proton Ceramic Electrolyte ...

Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...

Aravind Ayyagari spearheaded a comprehensive security infrastructure overhaul at Ramsell Corporation, implementing a ...

Truist Financial analyst Jailendra Singh maintained a Buy rating on Evolent Health (EVH – Research Report) today and set a price target of ...

After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...

In a report released today, Constantine Davides from JMP Securities maintained a Buy rating on Evolent Health (EVH – Research Report), with a ...

Governor Mike Braun signs multiple executive orders in Indiana, addressing affordable health insurance, abortion, and healthcare transparency.

James analyst Gary Nachman maintained an Outperform rating on AbbVie stock (NYSE:ABBV) with a $218.00 price target. The ...

Although the entire transmission process for a prescription claim from the time a pharmacist transmits it to the time the pharmacy receives payment authorization from the PBM on behalf of the ...

CVS Health owns Caremark and Cordavis, and its PBM's formulary contains a Cordavis-branded biosimilar. "Confusing? Absolutely. Profitable for the PBMs? Certainly. Good for plan sponsors and patients?